Company profile · Biotech & medical
G&E Herbal Biotechnology
德英生物科技股份有限公司 · 4911
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
G&E Herbal Biotechnology develops botanical new drugs, pharmaceuticals, functional skincare products, and health supplements.[1]
The manufacturing and sales of pharmaceuticals account for approximately 81.07% of revenue, food products for approximately 17.49%, and cosmetics for approximately 1.44%.[2]
The company's new drugs utilize native Taiwanese plants cultivated by farmers under contract.[2]
Developed dosage forms of SR-T100 include gels, injections, and capsules for treating conditions such as squamous cell carcinoma in situ, condyloma acuminatum, and verruca vulgaris.[2]
Hepanamin is a liver disease treatment drug approved by the Ministry of Health and Welfare.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$12m | -50.7% | +1.4% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 18 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$0m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | G&E Herbal Biotechnology Co., Ltd. |
|---|---|
| Chinese name | 德英生物科技股份有限公司 |
| Stock code | 4911 (TPEx) |
| Industry | Biotech & medical |
| Founded | 06 Aug 2002 |
| Listed | 21 Mar 2011 |
| Paid-in capital | NT$688m |
| Chairman | 郭國華 |
| President | 郭國華 |
| Headquarters | No.92,Keji 5th Rd., Annan Dist., Tainan City Annan Dist., Tainan 70955, Taiwan |
| Website | https://www.geherbs.com.tw |
| Official business description | SR-T100新藥開發、藥品、功能性保養品、保健食品的研發與製造 · OEM/ODM |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 德英生物科技股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list